These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 8781318)

  • 21. Basic fibroblast growth factor regulates expression of heparan sulfate in human periodontal ligament cells.
    Shimabukuro Y; Ichikawa T; Terashima Y; Iwayama T; Oohara H; Kajikawa T; Kobayashi R; Terashima H; Takedachi M; Terakura M; Hashikawa T; Yamada S; Murakami S
    Matrix Biol; 2008 Apr; 27(3):232-41. PubMed ID: 18036796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
    Yamagata E; Kamada A
    J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration.
    Cornelison DD; Filla MS; Stanley HM; Rapraeger AC; Olwin BB
    Dev Biol; 2001 Nov; 239(1):79-94. PubMed ID: 11784020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental expression of the syndecans: possible function and regulation.
    Bernfield M; Hinkes MT; Gallo RL
    Dev Suppl; 1993; ():205-12. PubMed ID: 8049475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
    Viklund L; Loo BM; Hermonen J; El-Darwish K; Jalkanen M; Salmivirta M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):146-52. PubMed ID: 11779146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
    Dobra K; Nurminen M; Hjerpe A
    Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of heparan sulfate in interactions of Listeria monocytogenes with enterocytes.
    Henry-Stanley M; Hess DJ; Erickson E; Garni RM; Wells C
    Med Microbiol Immunol; 2003 May; 192(2):107-15. PubMed ID: 12684756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells.
    Gallai M; Kovalszky I; Knittel T; Neubauer K; Armbrust T; Ramadori G
    Am J Pathol; 1996 May; 148(5):1463-71. PubMed ID: 8623917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shedding light on the distinct functions of proteoglycans.
    Selleck SB
    Sci STKE; 2006 Apr; 2006(329):pe17. PubMed ID: 16595733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proteoglycans in the liver].
    Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z
    Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?
    Zhou FY; Owens RT; Hermonen J; Jalkanen M; Höök M
    Eur J Cell Biol; 1997 Jun; 73(2):166-74. PubMed ID: 9208230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture.
    Rescan PY; Loréal O; Hassell JR; Yamada Y; Guillouzo A; Clément B
    Am J Pathol; 1993 Jan; 142(1):199-208. PubMed ID: 7678718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine.
    Nakanishi T; Kadomatsu K; Okamoto T; Ichihara-Tanaka K; Kojima T; Saito H; Tomoda Y; Muramatsu T
    J Biochem; 1997 Feb; 121(2):197-205. PubMed ID: 9089390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium.
    Patterson AM; Gardner L; Shaw J; David G; Loreau E; Aguilar L; Ashton BA; Middleton J
    Arthritis Rheum; 2005 Aug; 52(8):2331-42. PubMed ID: 16052590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype.
    Baba F; Swartz K; van Buren R; Eickhoff J; Zhang Y; Wolberg W; Friedl A
    Breast Cancer Res Treat; 2006 Jul; 98(1):91-8. PubMed ID: 16636895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
    Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
    Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of syndecan-1 in prostate cancer.
    Kiviniemi J; Kallajoki M; Kujala I; Matikainen MT; Alanen K; Jalkanen M; Salmivirta M
    APMIS; 2004 Feb; 112(2):89-97. PubMed ID: 15056224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PR-39 coordinates changes in vascular smooth muscle cell adhesive strength and locomotion by modulating cell surface heparan sulfate-matrix interactions.
    Chon JH; Houston MM; Xu C; Chaikof EL
    J Cell Physiol; 2001 Nov; 189(2):133-43. PubMed ID: 11598898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.